Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Alert:
NEW YORK, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of...
Source: globenewswire.com
Stay updated with breaking news from Mabs Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of claims on behalf of...